Management of BMI >/= 25 - Diet, Exercise, and Behavior
Management of BMI >/= 30 - ANSWER Diet, exercise, behaviour, and medication
Management of BMI >/= 27 + comorbidities - ANSWER Diet, exercise, behaviour,
and medication
Management of BMI >/=35 + cormorbidity: ANSWER Bariatric surgery
Management of BMI >/= 40 - ANSWER Bariatric surgery.
Co-morbidities: T2DM.
HTN
OSA and other respiratory diseases.
NAFLD
OA
Lipid abnormalities
gastrointestinal disorders
Heart illness.
Medication assessment - ANSWER: Every month for three months, then every
three months.
,Effective weight loss rate - ANSWER >/=5% in three months
Avoid these weight-loss medications with HTN/HD - ANSWER Sympathomimetic
(phentermine/diethylpropion)
Avoid these weight loss drugs with CVD: ANSWER Sympathomimetic
T2DM treatment plus weight loss medications: ANSWER GLP-1 analogue
(reduces insulin-related weight gain) or SGLT-2 inhibitors plus metformin. If using
insulin, I prefer basal instead of combo.
Drugs that cause weight gain - ANSWER Tricyclic antidepressants (amitriptyline)
oral contraceptives (Ortho Tri-Cyclen and Yaz)
antipsychotics (risperidone)
anticonvulsants
Glucocorticoids (cortisol).
sulfonylureas (Glimepiride and Glipizide)
Glitazones (Actos)
B-blockers (propranolol, metoprolol, and atenolol)
Hormonal signals for appetite - Answer: CCK-duodenum.
K cells in the duodenum and jejunum: Gatric inhibitory polypeptide.
PYY: ileum and colon.
GLP-1 in the ileum
,Pancreas - Insulin
Adipose tissue: leptin.
Liver- glucagon
GLP-1 is secreted in reaction to glucose, which increases insulin release from the
pancreas and satiety.
Ghrelin is produced in the stomach and is orexigenic.
Leptin is proportional to fat mass and has anorexigenic properties.
Answer for Phentermine/Topiramate (Qysemia): Phentermine is a stimulant.
Topiramate: neurostabilizer + antiseizure
Bupropion (Wellbutrin) - ANSWER Dopamine and norepinephrine reuptake
inhibitor
stimulates POMC neurons.
Sibutramine (Meridia) - Discontinued-
Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic
Approved for usage by teenagers over the age of 16
ANSWER: Orlistat limits the absorption of 25-30% of fat calories.
SLGT-2 inhibitors (optimal for T2DM patients)--ex. Invokana - ANSWER
promotes weight loss by blocking the reabsorption of carbohydrates and water.
Band name: Victoza/Sandexa, ANSWER Liraglutide
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller luzlinkuz. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R197,41. You're not tied to anything after your purchase.